GlassScriptPhysician profile
Crysten B Kragel
NPI 1235366600
$9,482.68
in general payments reported to CMS, 2019-2025
52 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $349 · 2021: $473 · 2022: $733 · 2023: $1,909 · 2024: $2,776 · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,843 · Education: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,843.16 |
| Education | $241.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,164.13 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Abbvie INC. | $1,055.85 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $747.61 | 2019-2025 | |
| Mdd US Operations, LLC | $566.16 | 2019-2025 | Gocovri, Xadago, Apokyn |
| Novartis Pharmaceuticals Corporation | $464.39 | 2019-2025 | |
| Biogen, INC. | $443.64 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Tg Therapeutics, INC. | $409.09 | 2023-2025 | |
| Axsome Therapeutics, INC. | $407.15 | 2023-2025 | Sunosi |
| Resmed Corp | $399.40 | 2020-2025 | |
| Inspire Medical Systems, INC. | $320.15 | 2022-2025 | Inspire |
| Supernus Pharmaceuticals, INC. | $295.21 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $260.87 | 2019-2025 | Ultomiris |
| Harmony Biosciences LLC | $231.05 | 2020-2024 | Wakix |
| Lilly USA, LLC | $214.67 | 2021-2025 | Reyvow, Emgality, Amyvid |
| Argenx US, INC. | $209.87 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crysten Kragel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.